Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Issue : The Pharmaceutical Journal, 31 January 2015, Vol 294, No 7847

Sort by: Newest first Oldest first A-Z Z-A

  • Administration of ciclosporin not recommended with Olysio Subscription

    22 JAN 2015 15:02

    The summary of product characteristics for Olysio (simeprevir; Janssen-Cilag) now states that co-administration with ciclosporin is not recommended because this leads to significantly higher exposure of simeprevir. 

  • 41.5% of US adults who drink alcohol report taking medicines known to interact with alcohol

    Almost 42% of US drinkers report taking drugs that interact with alcohol Subscription

    22 JAN 2015 14:56

    Some 41.5% of US adults who drink alcohol report taking medicines known to interact with alcohol, according to research published in Alcoholism: Clinical and Experimental Research.

  • UK deaths from coronary heart disease (CHD) have declined by 60% since the 1970s

    Analysis questions value of primary prevention medication for reducing CHD deaths Subscription

    27 JAN 2015 12:13

    Population-wide approaches to risk-factor control have had a far greater impact on the reduction of deaths from coronary heart disease than use of primary prevention medication.

  • David Taylor, pharmacist, academic and one of the top clinical leaders in Britain in 2014

    Answering clinical conundrums as a psychiatry research leader Subscription

    19 JAN 2015 16:35 By Stephen Robinson

    Pharmacist and academic David Taylor, lead author of ‘The Maudsley prescribing guidelines’, was named as one of the top clinical leaders in Britain in 2014. He discusses why he believes pharmacy’s future lies in clinical aspects of care and research.

  • Antifungal agents interactions app and databases Subscription

    22 JAN 2015 14:40

    The Fungal Infection Trust and the National Aspergillosis Centre have developed a freely available online resource and app for iPhone, iPad and Android devices, which displays potential interactions between antifungal agents and other medicines. The collaboration supported the development of two databases, one for patients and

  • Survey shows that in patients who have taken aspirin as primary prevention, treatment was inappropriate in nearly 11.6% of cases

    Aspirin inappropriately used for CVD prevention in just over 10% of cases Subscription

    29 JAN 2015 15:12
    Comments (1)

    A survey of nearly 70,000 patients taking aspirin for primary prevention has found that, for the overall cohort, treatment was inappropriate in nearly 11.6% of cases.

  • Assisted dying laws Subscription

    19 JAN 2015 13:04

    14 January 2015: The Times and The Scotsman reported that Holyrood was considering new laws to allow assisted dying in Scotland. They focused on the fact that “doctors in Scotland have demanded a ‘conscience clause’ be inserted into new laws on assisted suicide”.

  • Audit highlights problem of patients taking NSAIDs without gastroprotection Subscription

    21 JAN 2015 9:54

    Many patients taking non-steroidal anti-inflammatory drugs are not co-prescribed gastroprotective agents, an audit of community pharmacies in England has found.

  • The Cancer Drugs Fund has undermined the National Institute for Health and Care Excellence and has provided a “get out of jail card” for pharmaceutical companies.

    Cancer Drugs Fund has undermined NICE, its chair admits Subscription

    20 JAN 2015 17:10 By Janna Lawrence

    The Cancer Drugs Fund has undermined the National Institute for Health and Care Excellence and has provided a “get out of jail card” for pharmaceutical companies, its chair says.

  • Chloroquine sulphate syrup has been discontinued Subscription

    22 JAN 2015 14:27

    Chloroquine sulphate syrup (Nivaquine; Sanofi) has been discontinued and will no longer be marketed in the UK. The expiry date for the last batch supplied is March 2015. Other chloroquine phosphate syrup preparations are not currently available in the UK. As an alternative, chloroquine phosphate is available in a tablet form used alone or in combination with proguanil. 

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.